Crystagen

Product Details – Crystagen

Crystagen is a synthetic tripeptide composed of three amino acids: glutamic acid (Glu), aspartic acid (Asp), and proline (Pro), linked through peptide bonds. It is structurally derived from short peptide sequences associated with thymic peptide research and is utilized in controlled laboratory environments.

In experimental settings, crystagen is studied for its interaction with cellular regulatory systems, particularly those associated with gene expression and intracellular signaling pathways. Its defined structure allows for consistent investigation of peptide-mediated modulation at the molecular level.

This compound is supplied strictly for laboratory research purposes and is not intended for consumption, medical, or diagnostic use.

Mechanism of Action

At the molecular level, crystagen is investigated for its influence on gene expression pathways within cellular systems. It is analyzed for its interaction with DNA-associated regulatory mechanisms, including transcriptional processes that govern protein synthesis and cellular signaling.

These interactions are studied in vitro to evaluate how peptide exposure influences transcription factors, gene activation patterns, and intracellular communication networks. Researchers focus on pathways associated with immune-related signaling and regulatory protein expression.

Additionally, crystagen is utilized to examine peptide-driven modulation of signaling pathways linked to cytokine activity and inflammatory mediators, contributing to a broader understanding of intracellular regulatory mechanisms under controlled experimental conditions.

Chemical Properties of Crystagen

Attribute	Details
Compound Name	Crystagen
Classification	Synthetic tripeptide
Molecular Formula	C14H19N3O9
Molecular Weight	359.3 g/mol
Synonyms	Glu-Asp-Pro; EDP
Primary Target	Gene expression and intracellular signaling pathways
Research Context	Transcriptional regulation and peptide signaling studies
Format	Research peptide (non-consumable)
Stability	Maintained under controlled laboratory storage conditions

Research Applications

Gene Expression Analysis

Crystagen is utilized in experimental systems to examine peptide influence on transcriptional activity. Researchers analyze how peptide interactions affect gene expression patterns and regulatory mechanisms at the molecular level.

Intracellular Signaling Studies

This compound is applied in studies investigating signaling pathways associated with cytokine activity and regulatory protein expression. These analyses focus on intracellular communication and pathway modulation.

Peptide-Cell Interaction Research

Crystagen supports investigations into how short peptides interact with cellular environments. These studies focus on understanding peptide-mediated signaling and regulatory network behavior.

Why Choose BehemothLabz to Buy Crystagen for Research

BehemothLabz supplies research-grade Crystagen produced under controlled laboratory conditions with strict quality assurance protocols in place. Each batch undergoes detailed analytical verification to ensure consistency in molecular composition and purity.

In addition, comprehensive documentation, including laboratory testing reports and sourcing transparency, supports reproducibility across experimental applications. BehemothLabz maintains a compliance-focused approach, ensuring that all compounds are supplied exclusively for laboratory-based investigation and analytical research.

Disclaimer

Crystagen is intended strictly for laboratory research and analytical purposes only. It is not designed for diagnostic procedures, therapeutic applications, or any form of in vivo study.

All references to biochemical pathways, receptor interactions, and enzymatic processes are provided solely within a research context. This compound must be handled only by qualified professionals within controlled laboratory environments, in accordance with applicable regulations and safety standards.

Any use outside of these defined research conditions is strictly prohibited.

References

• Сhervyakova, N. A., Linkova, N. S., Chalisova, N. I., Koncevaya, E. A., Trofimova, S. V., & Khavinson, V. K. (2014). Advances in gerontology = Uspekhi gerontologii, 27(1), 224–228. https://pubmed.ncbi.nlm.nih.gov/28976144/
• Khavinson, V., Linkova, N., Kozhevnikova, E., Dyatlova, A., & Petukhov, M. (2022). Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers. International journal of molecular sciences, 23(14), 7733. https://doi.org/10.3390/ijms23147733